Literature DB >> 4566727

Type IV hyperlipoproteinemia. Clofibrate without dietary therapy.

R Zelis, E A Amsterdam, J F Spann, D T Mason.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4566727

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Effect of polyenyl phosphatidyl choline on clofibrate-induced increase in LDL cholesterol.

Authors:  J Schneider; R Müller; W Buberl; H Kaffarnik; R Schubotz; L Hausmann; G Mühlfellner; O Mühlfellner
Journal:  Eur J Clin Pharmacol       Date:  1979-02-19       Impact factor: 2.953

2.  Effects of clofibrate on glucose tolerance, serum insulin, serum lipoproteins and plasma fibrinogen.

Authors:  H Lithell; J Boberg; H Hedstrand; K Hellsing; S Ljunghall; B Vessby
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

Review 3.  Lipid lowering drugs and hyperlipidaemia.

Authors:  R I Levy; B M Rifking
Journal:  Drugs       Date:  1973       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.